Search
  1. Home
  2. East Africa
  3. Uganda
  • News

HIV/AIDS vaccine trials to begin this week

    JOHANNESBURG
    Phase one trials of an HIV vaccine are set to begin after a seven-month delay, the Uganda Virus Research Institute (UVRI) said on Monday. "The selection and approval of candidates is what caused the delay, but we are now ready to begin safety tests," URVI's head of immunology, Dr. Pontiano Kaleebu, told the UN news service Plusnews. Kaleebu said the vaccine DNA-MVA will target the HIV subtype A, found to be most prevalent in East Africa. "The vaccine preparations have been going on for the past three-and-a-half years at the UVRI. While it is still too early to celebrate, many stakeholders have expressed their hopefulness in the success of the trials," Kaleebu said. Kallebu said the 50 volunteers between the age of 18-50 would get four vaccine injections over a period of 18 months.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join